documents: FDA-2004-N-0188-0075

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2004-N-0188-0075 FDA FDA-2004-N-0188 Reference 8B Inactivation of the bovine-spongiform-encephalopathy (BSE) agent by the acid and alkaline processes used in the manufacture of bone gelatine re Use of Materials Derived From Cattle in Human Food and Cosmetics Supporting & Related Material Background Material 2016-03-18T04:00:00Z 2016 3     2016-03-18T16:53:55Z   0 0 0900006481ecef4d

Links from other tables